Abalone Bio
Emeryville
About Abalone Bio
Abalone Bio develops pharmacologically antibody drugs to successfully treat metaolic and inflammatory diseases where other drugs fail
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $12.9M
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: abalonebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Product Research
Social Profiles
Canonical: https://fsome.com/organization/abalone-bio-75790 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.